Skip to main content
Log in

Nach Operation oder Strahlentherapie der Axilla

Das Lymphödemrisiko von Mammakarzinompatientinnen

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

1

Literatur

  1. Naoum GE et al. J Clin Oncol. 2020;38(29):3430-8

  2. Poortmans PM et al. N Engl J Med. 2015;373(4):317-27

  3. Whelan TJ et al. N Engl J Med. 2015;373(4):307-16

  4. Donker M et al. Lancet Oncol. 2014;15(12):1303-10

  5. Gillespie TC et al. Gland Surg. 2018;7(4):379-403

  6. Giuliano AE et al. JAMA. 2017;318(10):918-26

  7. Liljegren G, Holmberg L. Eur J Cancer. 1997;33(2):193-9

  8. Galimberti V et al. Lancet Oncol. 2013;14(4):297-305

  9. Dylke ES et al. Oncologist. 2013;18(11):1242

  10. Ancukiewicz M et al. Int J Radiat Oncol Biol Phys. 2011;79(5):1436-43

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duma, M. Das Lymphödemrisiko von Mammakarzinompatientinnen. InFo Hämatol Onkol 24, 38–39 (2021). https://doi.org/10.1007/s15004-021-8779-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8779-3

Navigation